<rst>
<header>
	<relations>
			<rel name="purpose" type="rst"/>
			<rel name="result" type="rst"/>
			<rel name="elaboration" type="rst"/>
			<rel name="circumstance" type="rst"/>
			<rel name="preparation" type="rst"/>
			<rel name="restatement" type="rst"/>
			<rel name="means" type="rst"/>
			<rel name="attribution" type="rst"/>
			<rel name="joint" type="multinuc"/>
			<rel name="same_unit" type="multinuc"/>
		</relations>
</header>
<body>
<segment id="1" parent="1001" relname="preparation">1. Introduction</segment>
<segment id="2" parent="1002" relname="span">Aging-associated disabilities are generated by an accumulation of randomly occurring molecular damages during life time ,</segment>
<segment id="3" parent="2" relname="elaboration">which affect the organism at multiple levels such as metabolism , immune response , repair , and regeneration as well as altered inter- and intracellular communication .</segment>
<segment id="4" parent="1004" relname="span">Typical alterations</segment>
<segment id="5" parent="1005" relname="same_unit">detectable in aged tissues</segment>
<segment id="6" parent="1007" relname="span">are increased concentrations of reactive oxygen species</segment>
<segment id="7" parent="6" relname="restatement">( ROS )</segment>
<segment id="8" parent="1006" relname="joint">and concomitant increased DNA-damage , lipid and protein oxidation .</segment>
<segment id="9" parent="1010" relname="span">Often this is accompanied by accumulation of insoluble protein aggregates</segment>
<segment id="10" parent="9" relname="restatement">( lipofuscin )</segment>
<segment id="11" parent="1009" relname="same_unit">at least partially as a consequence of impaired proteasome function .</segment>
<segment id="12" parent="1011" relname="joint">In addition , glycation was reported to contribute to limited degradation and function of proteins .</segment>
<segment id="13" parent="1013" relname="span">Glycation represents an important posttranslational modification</segment>
<segment id="14" parent="1014" relname="joint">that significantly increases during aging</segment>
<segment id="15" parent="1015" relname="span">and results in the formation of advanced glycation end products</segment>
<segment id="16" parent="15" relname="elaboration">( AGEs ) .</segment>
<segment id="17" parent="1018" relname="span">AGEs are generated by an initial non-enzymatic reaction of amino groups with reactive carbonyl groups of monosaccharides</segment>
<segment id="18" parent="17" relname="elaboration">known as the Maillard reaction ,</segment>
<segment id="19" parent="1018" relname="result">thereby forming Schiff-base adducts .</segment>
<segment id="20" parent="1020" relname="span">These adducts are subsequently rearranged to so-called Amadori products</segment>
<segment id="21" parent="1021" relname="span">which undergo further oxidation and dehydration reactions</segment>
<segment id="22" parent="21" relname="elaboration">leading to a large group of heterogeneous products .</segment>
<segment id="23" parent="1022" relname="joint">Up to the stage of the Amadori products , adducts are basically reversible .</segment>
<segment id="24" parent="1024" relname="joint">Preferentially lysine residues ,</segment>
<segment id="25" parent="1025" relname="span">but also other amino acids</segment>
<segment id="26" parent="25" relname="elaboration">including arginine , histidine , tryptophan , or cysteine , are modified by glycation .</segment>
<segment id="27" parent="1031" relname="span">The most prominent and well-known AGEs</segment>
<segment id="28" parent="27" relname="elaboration">identified in cells and tissues</segment>
<segment id="29" parent="1030" relname="same_unit">are carboxymethyllysine</segment>
<segment id="30" parent="1030" relname="elaboration">( CML ) , carboxyethyllysine</segment>
<segment id="31" parent="1029" relname="elaboration">( CEL ) , pentosidine , and desoxyglucosone .</segment>
<segment id="32" parent="1032" relname="same_unit">Physiologically , these AGEs are formed in response to so-called “ dicarbonyl stress ”</segment>
<segment id="33" parent="1035" relname="span">as given under conditions of hyperglycemia or in the presence of highly reactive α-dicarbonyls</segment>
<segment id="34" parent="33" relname="restatement">( α-DCs ) such as glyoxal</segment>
<segment id="35" parent="1035" relname="elaboration">( GO ) ,</segment>
<segment id="36" parent="1037" relname="span">methylglyoxal</segment>
<segment id="37" parent="36" relname="restatement">( MGO )</segment>
<segment id="38" parent="1036" relname="same_unit">or 3-deoxyglucosone .</segment>
<segment id="39" parent="1039" relname="joint">These α-DCs are inevitable byproducts of anaerobic glycolysis and lipid peroxidation</segment>
<segment id="40" parent="1040" relname="span">and in consequence , induce the formation of highly stable AGEs</segment>
<segment id="41" parent="1041" relname="joint">which crosslink proteins</segment>
<segment id="42" parent="1041" relname="joint">and lead to protease-resistant protein aggregates .</segment>
<segment id="43" parent="1043" relname="span">In this context , glycation-induced modifications of extracellular matrix proteins</segment>
<segment id="44" parent="1044" relname="joint">resulting in intermolecular crosslinks lead to increased stiffness of tissues and vessels</segment>
<segment id="45" parent="1044" relname="joint">and affect cell migration .</segment>
<segment id="46" parent="1046" relname="span">Furthermore , there is clear evidence</segment>
<segment id="47" parent="46" relname="elaboration">that glycation and AGEs lead to mitochondrial dysfunction and impaired immune responses .</segment>
<segment id="48" parent="1049" relname="span">Glycation of growth factors such as platelet-derived growth factor</segment>
<segment id="49" parent="48" relname="restatement">( PDGF )</segment>
<segment id="50" parent="1050" relname="span">and insulin , as well as receptors such as nerve growth factor</segment>
<segment id="51" parent="50" relname="elaboration">( NGF)-receptor , were reported to affect signaling functions .</segment>
<segment id="52" parent="1053" relname="span">In addition , AGE modification itself can induce signaling mainly through the receptor for advanced glycation end products</segment>
<segment id="53" parent="52" relname="elaboration">( RAGE ) , a multi-ligand transmembrane receptor</segment>
<segment id="54" parent="1053" relname="elaboration">containing immunoglobulin domains .</segment>
<segment id="55" parent="1055" relname="span">RAGE-induced signaling contributes to aging-related inflammation and metabolic diseases</segment>
<segment id="56" parent="1056" relname="span">by modulation of multiple pathways</segment>
<segment id="57" parent="1057" relname="span">including phosphoinositide 3-kinase</segment>
<segment id="58" parent="57" relname="elaboration">( PI3K ) ,</segment>
<segment id="59" parent="1059" relname="preparation">Erk1/2 and Wnt signaling .</segment>
<segment id="60" parent="1060" relname="joint">However , the outcome of AGEs and RAGE signaling appears to be a double-edged sword with degenerative and protective effects .</segment>
<segment id="61" parent="1061" relname="joint">This also appears to be true in respect to the role of Wnt signaling in aging .</segment>
<segment id="62" parent="1062" relname="span">The canonical Wnt/β-catenin signaling cascade acts as a pivotal regulator of developmental and pathogenesis pathways</segment>
<segment id="63" parent="62" relname="elaboration">including cell stemness maintenance/differentiation , carcinogenesis , and aging-related phenotypes .</segment>
<segment id="64" parent="1063" relname="joint">Moreover , there is clear evidence for a role of the Wnt pathway in mitochondrial respiratory capacity and metabolic homeostasis , especially of glucose metabolism .</segment>
<segment id="65" parent="1064" relname="joint">Within the canonical Wnt signaling pathway , β-catenin is the central player .</segment>
<segment id="66" parent="1065" relname="joint">Normally , excess β-catenin is rapidly degraded by the ubiquitin-proteasome pathway .</segment>
<segment id="67" parent="1067" relname="joint">Activation of the pathway leads to the stabilization of β-catenin</segment>
<segment id="68" parent="1068" relname="span">and its accumulation within the cytosol and the nucleus ,</segment>
<segment id="69" parent="1070" relname="span">where it interacts with T-cell factor/lymphoid enhancer-binding factor</segment>
<segment id="70" parent="69" relname="restatement">( TCF/LEF )</segment>
<segment id="71" parent="1071" relname="span">transcription factors</segment>
<segment id="72" parent="71" relname="result">and thereby regulates transcription of multiple target genes .</segment>
<segment id="73" parent="1073" relname="span">During recent years , a multitude of other crosstalks and co-operations</segment>
<segment id="74" parent="73" relname="elaboration">affecting the pathway have been identified .</segment>
<segment id="75" parent="1076" relname="span">Interestingly , variants of the TCF-4</segment>
<segment id="76" parent="75" relname="elaboration">( TCF7L2 ) gene have been associated with increased risk of type 2 diabetes .</segment>
<segment id="77" parent="1077" relname="span">Based on that knowledge ,</segment>
<segment id="78" parent="1079" relname="attribution">we hypothesized</segment>
<segment id="79" parent="1079" relname="joint">that Wnt ligands as secreted , cysteine-rich proteins are susceptible to α-DC-mediated modifications</segment>
<segment id="80" parent="1079" relname="joint">and that glycation might modulate their signaling activities .</segment>
<segment id="81" parent="1082" relname="span">For this study , we decided to use Wnt3a as a proof of principle</segment>
<segment id="82" parent="81" relname="purpose">to study effects of GO-treatment on Wnt3a conditioned medium</segment>
<segment id="83" parent="1082" relname="restatement">( Wnt3a CM ) .</segment>
<segment id="84" parent="85" relname="attribution">We observed</segment>
<segment id="85" parent="1084" relname="span">that the ratio of phospho-β-catenin to total β-catenin increased .</segment>
<segment id="86" parent="87" relname="circumstance">As a further consequence , Wnt3a-induced activation of the β-catenin/TCF transcription complex was reduced</segment>
<segment id="87" parent="1085" relname="span">as shown by reporter gene assays and by decreased expression of endogenous Wnt target genes .</segment>
<group id="1000" type="span" />
<group id="1001" type="span" parent="1000" relname="span"/>
<group id="1002" type="span" parent="1001" relname="span"/>
<group id="1003" type="multinuc" parent="1002" relname="elaboration"/>
<group id="1004" type="span" parent="1003" relname="joint"/>
<group id="1005" type="multinuc" parent="4" relname="elaboration"/>
<group id="1006" type="multinuc" parent="1005" relname="same_unit"/>
<group id="1007" type="span" parent="1006" relname="joint"/>
<group id="1008" type="multinuc" parent="1003" relname="joint"/>
<group id="1009" type="multinuc" parent="1008" relname="joint"/>
<group id="1010" type="span" parent="1009" relname="same_unit"/>
<group id="1011" type="multinuc" parent="1008" relname="joint"/>
<group id="1012" type="multinuc" parent="1011" relname="joint"/>
<group id="1013" type="span" parent="1012" relname="joint"/>
<group id="1014" type="multinuc" parent="13" relname="elaboration"/>
<group id="1015" type="span" parent="1014" relname="joint"/>
<group id="1016" type="span" parent="1012" relname="joint"/>
<group id="1017" type="span" parent="1016" relname="span"/>
<group id="1018" type="span" parent="1017" relname="span"/>
<group id="1019" type="multinuc" parent="1017" relname="elaboration"/>
<group id="1020" type="span" parent="1019" relname="joint"/>
<group id="1021" type="span" parent="20" relname="elaboration"/>
<group id="1022" type="multinuc" parent="1019" relname="joint"/>
<group id="1023" type="multinuc" parent="1022" relname="joint"/>
<group id="1024" type="multinuc" parent="1023" relname="joint"/>
<group id="1025" type="span" parent="1024" relname="joint"/>
<group id="1026" type="multinuc" parent="1023" relname="joint"/>
<group id="1027" type="multinuc" parent="1026" relname="joint"/>
<group id="1028" type="span" parent="1027" relname="joint"/>
<group id="1029" type="span" parent="1028" relname="span"/>
<group id="1030" type="multinuc" parent="1029" relname="span"/>
<group id="1031" type="span" parent="1030" relname="same_unit"/>
<group id="1032" type="multinuc" parent="1027" relname="joint"/>
<group id="1033" type="multinuc" parent="1032" relname="same_unit"/>
<group id="1034" type="span" parent="1033" relname="joint"/>
<group id="1035" type="span" parent="1034" relname="span"/>
<group id="1036" type="multinuc" parent="1033" relname="joint"/>
<group id="1037" type="span" parent="1036" relname="same_unit"/>
<group id="1038" type="multinuc" parent="1026" relname="joint"/>
<group id="1039" type="multinuc" parent="1038" relname="joint"/>
<group id="1040" type="span" parent="1039" relname="joint"/>
<group id="1041" type="multinuc" parent="40" relname="elaboration"/>
<group id="1042" type="multinuc" parent="1038" relname="joint"/>
<group id="1043" type="span" parent="1042" relname="joint"/>
<group id="1044" type="multinuc" parent="43" relname="elaboration"/>
<group id="1045" type="multinuc" parent="1042" relname="joint"/>
<group id="1046" type="span" parent="1045" relname="joint"/>
<group id="1047" type="multinuc" parent="1045" relname="joint"/>
<group id="1048" type="multinuc" parent="1047" relname="joint"/>
<group id="1049" type="span" parent="1048" relname="same_unit"/>
<group id="1050" type="span" parent="1048" relname="same_unit"/>
<group id="1051" type="multinuc" parent="1047" relname="joint"/>
<group id="1052" type="span" parent="1051" relname="joint"/>
<group id="1053" type="span" parent="1052" relname="span"/>
<group id="1054" type="multinuc" parent="1051" relname="joint"/>
<group id="1055" type="span" parent="1054" relname="joint"/>
<group id="1056" type="span" parent="55" relname="means"/>
<group id="1057" type="span" parent="56" relname="elaboration"/>
<group id="1058" type="span" parent="1054" relname="joint"/>
<group id="1059" type="multinuc" parent="1058" relname="span"/>
<group id="1060" type="multinuc" parent="1059" relname="joint"/>
<group id="1061" type="multinuc" parent="1060" relname="joint"/>
<group id="1062" type="span" parent="1061" relname="joint"/>
<group id="1063" type="multinuc" parent="1059" relname="joint"/>
<group id="1064" type="multinuc" parent="1063" relname="joint"/>
<group id="1065" type="multinuc" parent="1064" relname="joint"/>
<group id="1066" type="span" parent="1065" relname="joint"/>
<group id="1067" type="multinuc" parent="1066" relname="span"/>
<group id="1068" type="span" parent="1067" relname="joint"/>
<group id="1069" type="multinuc" parent="68" relname="elaboration"/>
<group id="1070" type="span" parent="1069" relname="same_unit"/>
<group id="1071" type="span" parent="1069" relname="same_unit"/>
<group id="1072" type="multinuc" parent="1067" relname="elaboration"/>
<group id="1073" type="span" parent="1072" relname="joint"/>
<group id="1074" type="multinuc" parent="1072" relname="joint"/>
<group id="1075" type="span" parent="1074" relname="joint"/>
<group id="1076" type="span" parent="1075" relname="span"/>
<group id="1077" type="span" parent="1076" relname="elaboration"/>
<group id="1078" type="span" parent="77" relname="elaboration"/>
<group id="1079" type="multinuc" parent="1078" relname="span"/>
<group id="1080" type="multinuc" parent="1074" relname="joint"/>
<group id="1081" type="span" parent="1080" relname="joint"/>
<group id="1082" type="span" parent="1081" relname="span"/>
<group id="1083" type="multinuc" parent="1080" relname="joint"/>
<group id="1084" type="span" parent="1083" relname="joint"/>
<group id="1085" type="span" parent="1083" relname="joint"/>
	</body>
</rst>
